EZH2 is critical for the activation of resting B-cells and their entry into the cell cycle during germinal center (GC) development. As such, activation of PcGs through mutation or overexpression is commonly observed in B-cell leukemias and lymphomas. The gene discussed is EZH2; the disease is lymphoma.